Peripheral arterial disease (PAD) continues to grow in global prevalence and consumes an
increasing amount of resources in the United States health care system. Overall rates of …

The prevalence of peripheral artery disease (PAD) continues to increase worldwide. It is
important to identify patients with PAD because of the increased risk of myocardial infarction …

Peripheral artery disease (PAD) is due to the blockage of the arteries supplying blood to the
lower limbs usually secondary to atherosclerosis. The most severe clinical manifestation of …

Unresolved inflammation is central to the pathophysiology of commonly occurring vascular
diseases such as atherosclerosis, aneurysm, and deep vein thrombosis—conditions that are …

Hemodynamic dysfunction mainly characterizes pathophysiology of peripheral arterial
disease (PAD) leading to chronic ischemia. Hemodynamic dysfunction is the origin of …

Background Patients with peripheral arterial disease (PAD) often remain undiagnosed and
therefore suboptimally managed. Here, we investigated the diagnostic and prognostic …

Background The aims of this study were:(1) to investigate changes in indices of oxidative
stress and inflammation in the evaluation of peripheral artery disease (PAD);(2) to compare …

Background Symptomatic peripheral artery disease (PAD) is an atherosclerotic occlusive
disease affecting the lower extremities. The cause of symptomatic PAD is atherosclerosis …

Background Beta-2 Microglobulin (β2M) is a prototypical “middle molecule” uremic toxin that
has been associated with a higher risk of death in hemodialysis patients. A quantitative …

Background Recent studies have shown an association between peripheral arterial disease
(PAD) and increased risk of mortality in hemodialysis (HD) patients; however, the estimates …